Inconsistent protective efficacy and marked polymorphism limits the value of Schistosoma japonicum tetraspanin-2 as a vaccine target by Zhang, Wenbao et al.
Inconsistent Protective Efficacy and Marked
Polymorphism Limits the Value of Schistosoma
japonicum Tetraspanin-2 as a Vaccine Target
Wenbao Zhang1, Jun Li1, Mary Duke1, Malcolm K. Jones2,3, Ling Kuang1, Jianfeng Zhang1, David Blair4,
Yuesheng Li1,5, Donald P. McManus1*
1Molecular Parasitology Laboratory, Australian Centre for International and Tropical Health and Nutrition, Queensland Institute of Medical Research, Brisbane,
Queensland, Australia, 2 Parasite Cell Biology Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland, Australia, 3 The School of Veterinary Science,
The University of Queensland, St Lucia, Queensland, Australia, 4 School of Marine and Tropical Biology, James Cook University, Townsville, Queensland, Australia, 5Hunan
Institute of Parasitic Diseases, Yueyang, China
Abstract
Background: Schistosoma mansoni tetraspanin 2 (Sm-TSP-2) has been shown to be strongly recognized by IgG1 and IgG3
antibodies from individuals putatively resistant to schistosome infection, but not chronically infected people, and to induce
high levels of protection against challenge infection in the murine model of schistosomiasis. Amplification by PCR of
homologous sequences from male and female S. japonicum worms showed the presence of 7 different clusters or
subclasses of S. japonicum TSP-2. We determined the protective efficacy of one subclass – Sj-TSP-2e.
Methodology/Principal Findings: Following the alignment of 211 cDNAs, we identified 7 clusters encoding S. japonicum
TSP-2 (Sj-TSP-2) based on sequence variation in the large extracellular loop (LEL) region with differing frequency of
transcription in male and female worms. Quantitative PCR analysis revealed elevated expression of Sj-TSP-2 in adult worms
compared with other life cycle stages. We expressed in E. coli the LEL region of one of the clusters which exhibited a high
frequency of transcription in female worms, and showed the purified recombinant protein (Sj-TSP-2e) was recognised by
43.1% of sera obtained from confirmed schistosomiasis japonica patients. Vaccination of mice with the recombinant protein
induced high levels of IgG1 and IgG2 antibodies, but no consistent protective efficacy against challenge infection was
elicited in three independent trials.
Conclusions/Significance: The highly polymorphic nature of the Sj-TSP-2 gene at the transcriptional level may limit the
value of Sj-TSP-2 as a target for future S. japonicum vaccine development.
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Introduction
There is now growing agreement that integrated control, which
could include the use of an effective vaccine combined with
chemotherapy and other measures, is the optimum direction that
the future control of schistosomiasis should follow [1,2]. Vaccine
development against schistosomiasis has been guided by the fact
that irradiated cercariae confer .80% protection in experimental
animal models and natural hosts including mice, rats, rabbits,
sheep and bovines [3].
A number of promising anti-schistosome vaccine candidates
exist but they may prove not to be the most effective and it is,
therefore, important to continue to identify new target antigens
and to explore alternative vaccination strategies to improve
vaccine efficacy [2]. A reporter-based signal sequence capture
technique identified two S. mansoni tetraspanins (Sm-TSP-1 and
TSP-2) [4], both proteins being expressed in the tegument
membrane [5]. The large extracellular loop (LEL) of Sm-TSP-2,
in particular, provided high levels of protection as a recombinant
vaccine in the mouse model of schistosomiasis, and both proteins
were strongly recognized by IgG1 and IgG3 from putatively
resistant individuals but not chronically infected people [5]. A
subsequent study showed that Sm-TSP-2 plays a role in the
formation of the S. mansoni tegument [6], which is critically
important for the parasite’s survival [7].
Following these studies on Sm-TSP-2, genes and gene subclasses
encoding TSP-2 homologues were isolated from S. japonicum (Sj-
TSP-2) [8]. However, mice vaccinated with the same LEL of Sj-
TSP-2 present in Sm-TSP-2 were not protected following a
challenge infection with S. japonicum [8]. The study showed also
that Sj-TSP-2 is highly polymorphic and, as a result, these authors
argued against further development of Sj-TSP-2 as a vaccine
candidate against schistosomiasis japonica [8]. Subsequently,
however, another group used a similar Sj-TSP-2 sequence to
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produce recombinant Sj-TSP-2 and obtained significant (46–58%
efficacy) in mice vaccinated with the protein and then challenged
[9]. In light of these contradictory results, we cloned and
sequenced a slightly different Sj-TSP-2 sequence (Sj-TSP-2e), and
expressed and purified its recombinant product. The Sj-TSP-2e
protein was recognised by sera from some patients positive for S.
japonicum infection, but the molecule did not protect mice using
either a high (35 cercariae) or low (12 cercariae) dose of S. japonicum
challenge infection.
Materials and Methods
Ethics statement
The conducts and procedures involving animal experiments
were approved by the Animal Ethics Committee of the Queens-
land Institute of Medical Research. Ethical approval for using
human sera for this study was granted by the Ethics Committee of
Hunan Institute of Parasitic Diseases, Hunan, China.
Parasites
Oncomelania hupensis infected with S. japonicum were obtained
from an endemic area in Anhui Province, China. Adult worms
were collected from two rabbits (each experimentally infected
with 200 cercariae) 7 weeks post-infection. Cercariae and
schistosomula were collected as previously described [10]. The
worms were stored in RNAlater (Ambion, Foster City, CA) at
270uC until use.
Total RNA extraction and cDNA synthesis
Total RNA was extracted from either a pool of 20 males or 30
female worms using an RNAeasy Mini Kit (Qiagen, Hilden,
Germany) to remove potential DNA contamination. The kit was
also used to extract total RNA from cercariae and schistosomula.
First strand cDNA was synthesized using a Sensiscript RT Kit
(Qiagen).
Cloning and sequence alignment of S. japonicum-TSP-2
Homology searches using BLAST showed that S. japonicum has a
range of sequences homologous to S. mansoni TSP-2. The cDNA
sequences are highly conserved at both termini. Accordingly, we
designed two primers: upstream; 59-ATGGCTCTCGGGTGTG-
GATACAAG-39 and downstream; 59-CTATTCATCATCGC-
CTCGTTTTATAGCC-39 to amplify the ORF of cDNA using
the first strand cDNA from males and females, respectively, as
templates. The PCR products were separated by running an
agarose gel and a DNA band matching the designated size was cut
and extracted using a Qiaquick Gel Extraction kit (Qiagen). The
DNA was then ligated into a cloning pGEMT vector (Promega,
Madison, WI). We sequenced 100 clones from each of the male
and female cDNA preparations to determine the distribution of
homologous sequences between male and female S. japonicum
worms. We used ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2/
index.html) and Bioedit (http://www.mbio.ncsu.edu/bioedit/bioedit.
html) for sequence alignment.
Phylogenetic analysis
Inferred amino acid sequences of the LEL portions of the
sequenced clones were aligned with homologues (TSP-2) identified
by BLAST searches in GenBank and with sequences reported by
Cai et al [8]. The sole relevant sequence from S. mansoni was used
as the outgroup. The alignment of the LEL region consisted of 77
sites of which 37 were variable. Phylogenetic analysis was done
using MrBayes [11]. The Jones model for amino-acid substitu-
tion+G (gamma distribution of rates with four rate categories)+I
(proportion of invariant sites) was used. Values for I and for the
shape parameter (alpha) for the gamma distribution were
estimated from the data during the runs. Two million generations
(2 runs each of 4 chains) were specified and the chain was sampled
every 1000 generations. The first 10% of sampled trees were
discarded as burnin. The standard deviation of split frequencies
was well below 0.01 by the end of the analysis.
Stage expression of S. japonicum-TSP-2 by quantitative
PCR
We used quantitative PCR to determine the expression level of Sj-
TSP-2 in four life cycle stages (adult male, adult female, cercaria and
schistosomulum) of S. japonicum using the up-stream primer: 59-
ACAATGTTGTGGTGCCGAATCGCC-39 and down-stream
primer: 59- CTATTCATCATCGCCTCGTTTTATAGCC-39.
After first strand cDNA synthesis, all the cDNA samples were
diluted to a concentration of 10 ng/ml. Subsequently, 5 ml aliquots
were combined with 10 ml of SYBR Green, 3 ml of water and 2 ml
(5 pmol) of the forward and reverse primers. Each experiment was
performed in triplicate. Expression profiles of Sj-TSP-2 in the
different stages were obtained by real time PCR using a Rotor Gene
(6000) real time PCR machine (Qiagen) and data were analysed by
Rotor Gene 6 Software. S. japonicum NADH-ubiquinone reductase
was employed as a house keeping gene [10] in the quantitative
analysis using the primers: 59-CGAGGACCTAACAGCAGAGG -
39 and 59- TCCGAACGAACTTTGAATCC-39.
Recombinant protein expression
To express the large extracellular loop (LEL) sequence (Glu107
to His180) of Sj-TSP-2e, we designed a pair of primers (59-
GAAAAGCCGAAGGTGAAAAGACA-39 and 59-GCGGTGC-
TTTTTAGTCAGATCGGTGA-39) to amplify the target frag-
ment and subcloned the sequence into the pBAD/Thio-TOPO
plasmid (Invitrogen). The fragment was fused in-frame with the N-
terminal thioredoxin (Thi) and the C-terminal V5 epitope (V5)
Author Summary
Schistosoma mansoni tetraspanin 2 (Sm-TSP-2) is consid-
ered a lead target for vaccine development against
schistosomiasis mansoni because: (1) It is located in the
schistosome tegument and is involved in tegument
formation; (2) It is strongly recognized by IgG1 and IgG3
antibodies from individuals putatively resistant to schisto-
some infection, but not chronically infected people, and (3)
It induces high levels of protection against challenge
infection in the mouse model. We amplified 211 homol-
ogous TSP-2 sequences from male and female S. japoni-
cum worms, which revealed 7 different cDNA subclasses.
We expressed in E. coli a region of one of the clusters
which exhibited a high frequency of transcription in
female worms, and showed the purified recombinant
protein (Sj-TSP-2e) was recognised by 43.1% of sera
obtained from confirmed schistosomiasis japonica pa-
tients. Vaccination of mice with the recombinant protein
induced high levels of IgG1 and IgG2 antibodies, but no
consistent protective efficacy against challenge infection
was elicited in three independent trials. The highly
polymorphic nature of the Sj-TSP-2 gene at the transcrip-
tional level may limit the value of Sj-TSP-2 as a target for
future S. japonicum vaccine development. Further analysis
of the distribution of the different subclasses/alleles of the
Sj-TSP-2 gene in S. japonicum populations from different
endemic areas would be informative.
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and 6His tags. The plasmid was transformed into E. coli.
Subsequent protein expression under native conditions was
conducted as recommended by the manufacturer. The recombi-
nant fusion protein (Sj-TSP-2e-Thi) from E. coli lysates was
purified under non-denaturing conditions using 6His affinity
chromatography (BD Biosciences). The identities of the purified
proteins were confirmed by Western blotting with antibodies to
thioredoxin and 6His epitopes. S. mansoni TSP-2 was kindly
provided by Professor Alex Loukas and was expressed as described
[5]. We designed a pair of primers: 59-GGGAATTCAAAATG-
TCTGAAAAGCCGAAGGTGAAAAGACA -39 and 59-GCCT-
CGAGGTGCTTTTTAGTCAGATCGGTGAC-39 to subclone
the LEL fragment into the pPICZ-c vector (Invitrogen) and
transformed into Pichia yeast (Invitrogen) according to the
manufacturer’s instructions. The generated protein was fused
with a His tag at the C terminal for affinity purification.
Immunolocalization
Murine anti-Sj-TSP-2e serum was produced as previously
described [12]. The serum was absorbed with laboratory made
‘‘beads’’ binding a bacterial lysate having the Thi protein tag to
remove antibodies against the Thi and His tag proteins and
bacterial proteins as described [12]. We then used Western
blotting to confirm that the anti-Sj-TSP-2e serum did not
recognize either the Thi tag or proteins in the bacterial lysate.
For immunolocalization, we collected fresh adult S. japonicum
worms from rabbits. The worms were fixed in 100% methanol,
embedded in Tissue-Tek Optimal Cutting Temperature (OCT)
compound (ProSciTech), and cryostatically sectioned into 7.0-mm
sections. The sections were blocked with 5% (w/v) skimmed milk
powder in PBS containing 0.1% (v/v) Tween 20 (PBST) as a
blocking solution (SMPT), incubated firstly with mouse anti–Sj-
TSP-2 serum diluted 1:25 with SMPT, and then by rabbit
antibody to mouse IgG conjugated to Cy2 (Jackson ImmunoR-
esearch; diluted 1:150 in SMPT). Sections were counterstained
with DAPI (Sigma; 0.1 mg/ml in PBS), which stains nuclei. We
mounted the slides with DAKO mounting medium and examined
them using a confocal microscope (Leica TCS SP2). Normal
mouse serum and murine serum raised against thioredoxin tagged
with 6 His were used as controls.
SDS-PAGE and Western blot analysis
A soluble adult worm antigen preparation (SWAP) of S.
japonicum was prepared from worms collected from rabbits after
5 washes with PBS. The worms were resuspended in PBS
containing protease inhibitor cocktail (Sigma, St. Louis, MO),
disrupted on ice using a homogenizer, and sonicated five times
using 10-second bursts. The suspension was centrifuged at
60,000 g at 4uC for 1 h, and the supernatant was stored at
280uC until use. The pellet was washed twice with PBS and
dissolved in 1% SDS (w/v) in PBS and heated at 56uC for 30 min.
The supernatant was used as a source of insoluble parasite proteins
after centrifugation at 60,000 g and at room temperature for 1 h.
For Western blotting, the protein preparations, including
SWAP, insoluble parasite proteins and recombinant proteins
were run on SDS-PAGE. The separated proteins were then
transferred onto a nitrocellulose membrane. After blocking in
SMPT, the membrane was incubated at 37uC for 1 h with the
murine anti-Sj-TSP-2 serum, diluted 1 in 1000, then incubated
with HRP labelled rabbit antibodies against mouse IgG for 1 h
after 3 washes with PBST. 4-chloro-1-naphthol was used as
substrate to develop the colour reaction using protocols previously
described [13,14].
Screening human and mouse sera by ELISA
Nunc Maxisorp Surface 96-well plates were coated with 100 ml
of 10 mg/ml of whole parasite protein preparation (5 mg/ml of
SWAP and 5 mg/ml of insoluble proteins for screening human
sera), 2 mg/ml of Sj-TSP-2 or Thi tag (for screening human and
mouse sera) in 0.06 M NaCO3, pH 9.6 overnight at 4uC. The
plates were then blocked with SMPT at 37uC for 1 h after two
washes with PBS.
Human sera from confirmed schistosomiasis japonica cases
(n = 72) by microscopy with fecal egg identification and serology
against adult worm antigens before treatment [15] were collected
from Han Chinese patients from endemic areas of Hunan
province, People’s Republic of China (PRC) and 24 normal sera
were collected from healthy Han Chinese from Xinjiang, PRC,
where schistosomiasis is not endemic. The human sera were
diluted 1 in 100 with SMPT. The remaining ELISA processing
steps were essentially as previously described [13,14].
Mouse serum isotypes were measured by ELISA based on
methods previously described with mini modification [16,17]. In
brief, mouse sera were diluted to 1 in 500 with in PBST for
detecting IgA, IgG and IgM antibodies, and 1:50 for IgE. 100 ml
of each diluted serum was added to each well, and plates were
incubated at 37uC for 1 h for IgA, IgG and IgM detection or
overnight at 4uC for IgE. This was followed by 4 washes with
PBST. Then anti-mouse IgG or IgG subclass was added at 1:3000
dilution, IgE at 1:2500 dilution and IgM at 1:10000 dilution
(Invitrogen) and the plates incubated for 1 h at 37uC, except for
IgE detection when the plates were incubated overnight at 4uC.
The plates were then washed five times with PBST. The assays
were developed in 2,2-azino-di-(ethyl-benzithiozolin sulphonate)
(ABTS) (Sigma) substrate solution for 30 min. The optical density
(OD) of the colour that developed in the plates was read at 405 nm
using an ELISA reader (VersaMax, East Falmouth, MA).
Mouse vaccination trials
Each vaccine trial undertaken comprised three groups of mice,
including two experimental groups each vaccinated separately
Table 1. Subclass distribution of S. japonicum tetraspanin 2
(Sj-TSP-2) in male and female worms.
Sj-TSP-2
Variable
region* Clones in
Males (%) Females (%)
Sj-TSP-2a TGKK 16 (14.8) 0 (0)
Sj-TSP-2b TGEK 0 (0) 0 (0)
Sj-TSP-2c SKGR 27 (25) 9 (8.7)
Sj-TSP-2d SRGP 32 (29.6) 36 (34.9)
Sj-TSP-2e SSER 4 (3.7) 24 (23.3)
Sj-TSP-2f TVRT 13 (12) 11 (10.7)
Sj-TSP-2g TVRT{ 0 (0) 0 (0)
Sj-TSP-2h{ SKER 12 (11.1) 8 (7.8)
Sj-TSP-2i{ FERR 4 (3.7) 15 (14.6)
Total - 108 - 103 -
*, The variable region of the Sj-TSP-2 protein sequence from amino acid 155 to
158 of the full-length sequences.
{, Two previously undescribed sequences;
{, same as Sj-TSP-2f in the variable region, which Cai et al. [8] suggested was a
different subclass as it contains substitutions in other regions.
doi:10.1371/journal.pntd.0001166.t001
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with Sj-TSP-2e and Sm-TSP-2 and one control group vaccinated
with thioredoxin (Thi) tag protein. Each group comprised 10
female CBA/J mice (18–22 g in weight and 6–8 weeks old).
Recombinant Sj-TSP-2e and Sm-TSP2 (25 mg per dose in 25 ml)
were formulated with an equal volume of either Freunds complete
(primary) or Freunds incomplete (two boosts at two weekly
intervals) adjuvants and the preparations were subcutaneously
injected into the mice. All mice were anaesthetised with a mixture
of ketamine (100 mg/kg body weight) and xylazine (20 mg/kg
body weight) 2 weeks after the final vaccine injection and
challenged percutaneously with S. japonicum cercariae by the cover
slip method. The mice were challenged with 35 (high dose) or 12
(low dose) cercariae.
The mice were sacrificed using CO2 at 7 weeks post-challenge
and necropsied to determine worm and liver egg burdens. Mice
were perfused with PBS to remove worms from the mesenteric
veins as described [18] and the numbers of male and female adult
parasites present counted. The mouse livers were weighed and
digested with 10 ml 5% (w/v) potassium hydroxide overnight at
37uC on a rocking platform. Liver eggs were then counted in
aliquots by light microscopy. Fecal egg counts were determined by
collecting fecal samples from each of the mice over a 48-h period
of 4 collections (0.3–0.5 g/mouse) before perfusion. The fecal
samples from each of the mice were pooled, weighed and mixed by
vortexing in PBS and then rotating overnight at 4uC. Fecal pellets
were obtained by centrifugation at 500 g for 10 min, resuspended
Figure 1. Protein sequence alignment of Schistosoma japonicum tetraspanin 2 (Sj-TSP-2) isolated from adult worms. The variable
region is boxed. The large extracellular loop region is indicated by a solid line. Sj-TSP-2a (M8-1 and M6-1, GenBank accession numbers JF264973 and
JF264974), Sj-TSP-2c (M2-11, JF264975), Sj-TSP-2d (M9-1, JF264977), Sj-TSP-2e (F2-2, JF264978), Sj-TSP-2f (F12-1, JF264982; F11-4, JF264983), Sj-TSP-2h
(F11-7, JF264979; F11-9, JF264980; F3-1, JF264981) and Sj-TSP-2i (M2-1, JF264976) were from individual male (M) and female (F) worms. For instance,
M8-1 represents number 8 male worm and number 1 clone.
doi:10.1371/journal.pntd.0001166.g001
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in 50 ml PBS and filtered through 600-mm and then 250-mm mesh
sieves. The filtered material was pelleted by centrifugation at 500 g
for 10 min and resuspended in 10 ml PBS. A 100-ml aliquot was
pipetted onto a microscope slide and the number of eggs in each
aliquot counted. For each sample, 10 aliquots (1000-ml of egg
suspension) were counted to obtain the total number of eggs in
10 ml and then the number of eggs-per-gram (e.p.g.) for each of
the mice determined.
The level of protection was expressed as a percentage based on
the reduction in worm burden and liver and faecal eggs in the
groups vaccinated with the Sj-TSP-2e and Sm-TSP-2 proteins
compared with the control groups.
Statistical analysis
A nonparametric Mann-Whitney U-test was used for analysis of
the vaccine trial data because of the relatively small sample size in
each experiment. Spearman’s rank correlation was used to analyze
the correlation between worm burden/egg numbers and serum
optical-density values in ELISA. We compared the median values
of each vaccine test group with the control groups to calculate
reductions in worm burden, and fecal and liver eggs. P,0.05 was
taken to indicate statistically significant differences.
Results
A region in the large extracellular loop region of Sj-TSP-2
is variable
BLAST analysis showed that a number of S. japonicum sequences
deposited in the GenBank and other databases were homologous
to Sm-TSP-2. The Sj-TSP-2 sequences at both the N and C
terminal ends are nearly identical, which allowed us to design
primers to amplify the full-length ORF of the cDNAs. We
sequenced 108 clones from male and 103 from female adult
worms (Table 1). The ORFs of the sequences were identical in
size, encoding a precursor protein of 215 amino acids. Protein
sequence analysis showed that all the proteins have a similar
structure containing four transmembrane domains and two loops
(Figures S1 and S2). Whereas the N and C termini are highly
conserved, the large loop region, which was used in the Sm-TSP-2
vaccine studies by Tran et al [5], is highly variable. The variation
results in 7 clusters and Fig. 1 and Table 1 show representatives of
each of the clusters. We compared the sequences with a previous
study [8] and showed that 5 of the clusters were identical to those
earlier reported as subclasses Sj-TSP-2a, c, d, e and f (Table 1). We
identified two additional clusters, Sj-TSP-2h and Sj-TSP-2i
(Table 1), but were unable to amplify any of the Sj-TSP-2b or
Sj-TSP-2g sequences described previously [8].
The gene clusters were differentially transcribed in male and
female S. japonicum; Table 1 shows their frequency of transcription
in male and female worms. Sj-TSP-2a was specifically expressed in
males whereas Sj-TSP-2e was more prominent in female worms
(Table 1).
A phylogenetic tree of the Sj-TSP-2 sequences found using
MrBayes is shown in Figure 2. Twelve different sequences for the
LEL were found in S. japonicum. These differed from each other by
between 1 and 22 sites. Pair-wise differences between any
sequence from S. japonicum and the homologue from S. mansoni
ranged from 28 to 33.
We used real time PCR to quantify the expression levels of Sj-
TSP-2 in different stages of S. japonicum with a pair of primers
designed from the identical regions of the clusters. The analysis
showed that Sj-TSP-2 was differentially transcribed in different
stages of the parasite, with the gene being expressed 6 and 30 times
higher in schistosomula and adult worms, respectively, than in
cercariae. In addition, expression of Sj-TSP-2 was 47-fold higher in
adult males and 8.7 times higher in adult females compared with
the cercariae (Fig. 3).
Expression and purification of Sj-TSP-2e
As the LEL region of Sm-TSP-2 was used successfully as a
vaccine for S. mansoni [5], we expressed the homologous region of
Sj-TSP-2e using the pBAD/Thio-TOPO plasmid expression
system; this expresses the target protein fused with thioredoxin.
Figure 2. Phylogenetic analysis of Sj-TSP-2 clusters with
homologues. Protein sequences corresponding to the LEL region of
Sj-TSP-2 encoded by 9 clusters of Sj-TSP-2 cDNAs were aligned with
additional homologues found by BLAST searches in GenBank and
others reported by Cai et al [8]. Analysis was done as stated in the text.
Clade credibility (posterior probability) values are shown at nodes.
Protein sequence data reported in this paper are available in the
GenBank, EMBL and DDBJ databases under the accession numbers
ABR27733, AAX26611 and CAX70617.
doi:10.1371/journal.pntd.0001166.g002
Figure 3. Expression levels of Sj-TSP-2e by real-time PCR.
cDNAs were amplified with mRNA isolated from different stages of S.
japonicum using specific primers designed from the conserved regions
of Sj-TSP-2e. Ce, cercariae; So, schistosomula; Pw, paired adult worms;
Ma, males; Fe, females. The bars (and *, X axis) show the fold changes
compared with the cercarial stage. We used NADH-ubiquinone
reductase as a house-keeping gene to calculate the number of copies
of the gene expressed in each of the stages, and then converted these
to fold changes by comparison with the number of copies in cercariae.
doi:10.1371/journal.pntd.0001166.g003
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As described earlier, we cloned several clusters of Sj-TSP-2 but we
expressed the Sj-TSP-2e subclass due to its high frequency of
transcription in females (Table 1), indicating its role in female
development, which is a target for vaccine development [2]. The
purity of Sj-TSP-2e and Sm-TSP-2 are shown in Fig. 4. In an
effort to increase antigenicity, we also employed a yeast expression
system to express the LEL region of Sj-TSP-2e (Fig. 4).
Antibody recognition of Sj-TSP-2e
We used three methods to characterize Sj-TSP-2e expression in
S. japonicum. Firstly, we extracted the whole repertoire of parasite
proteins including soluble and insoluble proteins. We then used
Western blotting to probe the native protein with hyper immune
mouse serum prepared against recombinant Sj-TSP-2e (Fig. 4). A
band of 38 kDa was recognized in the native protein preparations
(from worms collected from rabbits) by the immune serum; a
strong band was evident in the insoluble protein preparation and a
weaker band in the soluble fraction (Fig. 4).
Secondly, recombinant Sj-TSP-2e LEL was recognized by a
serum pool, from 15 randomly selected patients, with confirmed S.
japonicum infection, but the pool did not bind the Thi tag protein
(Fig. 5I). We coated the recombinant protein and native proteins
onto ELISA plates for screening 72 individual sera collected from
positive schistosomiasis japonica patients. All the sera recognised
the native proteins with different OD values (Fig. 5II). We reacted
the sera with Sj-TSP-2e-Thi protein; 43.1% (31/72) of the sera
had OD values 2.5-fold higher than the average OD values of
negative sera (Fig. 5II) and only one of the 72 sera reacted
positively with the Thi tag protein alone.
Thirdly, we used the hyper-immune mouse serum prepared
against recombinant Sj-TSP-2e to localize Sj-TSP-2e in female S.
japonicum. The results showed that specific antibodies against Sj-
TSP-2e bound to the tegument and gut of adult female worms
(Fig. 6). Sections of male worms showed minimal staining (data not
shown).
Vaccination of mice with Sj-TSP-2e
In order to determine whether Sj-TSP-2e had any protective
efficacy, three trials were undertaken; these comprised two
experiments where mice were challenged with a high dose of 35
cercariae, and one experiment where mice were challenged with a
low dose of 12 cercariae. Murine serum samples collected
throughout the course of the vaccine trials with Sj-TSP-2e did
not react in ELISA with thioredoxin fused with 6His alone (data
not shown), indicating the very poor antigenicity of this tag
protein. In contrast, the vaccinated mice generated high levels of
IgG against SjT-SP-2e after the second injection and these peaked
after the third injection; the serum titres dropped slightly just prior
to perfusion of the mice (Fig. 7). Of the IgG subclasses, IgG1
antibodies were dominant and IgG2a antibodies were also
increased significantly (Fig. 7). IgA, IgE and IgM were at
background levels throughout the three trials (Fig. 7). IgG
antibodies, including IgG1 and IgG2, in the sera collected from
mice vaccinated with Sm-TSP-2 recognized Sj-TSP-2e (Fig. 7),
indicating that the two antigens may share similar epitopes.
Table 2 shows the vaccination results of the three independent
trials. In the first trial, Sj-TSP-2e induced a low but significant
reduction in worm burden (36.4%, P,0.001) and liver eggs (26.5%,
P,0.05). Accordingly, we repeated the experiment but could not
corroborate the results in the second trial. We considered that the
challenge with 35 cercariae was so high that damage to the
established immune system in the mice could have occurred, and
thus we used a low dose challenge with 12 cercariae. Compared
with the control, however, no significant protection (Table 2) was
induced by Sj-TSP-2e in the vaccinated mice; there were 54.4%
and 68.9% reductions in liver and fecal eggs, respectively, in the
vaccinated mice but the reductions were not significant when
compared with the control groups. Sm-TSP-2 induced 70.9%
reduction in liver egg numbers but this was also not significant
(P.0.05) compared to the control group. In addition, antibody
levels (before challenge and perfusion) showed no correlation with
Figure 4. Purification and recognition of recombinant Sj-TSP-2e. Left panel, SDS-PAGE of soluble and insoluble proteins extracted from adult
S. japonicum and recombinant proteins. Right panel: Recognition of recombinant Sj-TSP-2e and native proteins by antibodies in hyper immune
mouse serum raised against recombinant Sj-TSP-2e. Lane M, protein markers; Lanes 1 and 2, soluble and insoluble proteins of S. japonicum; lane 3,
Thi; lane 4, Sj-TSP-2e-Thi; lane 5, Sj-TSP-2e expressed in Pichia yeast; lane 6, Sm-TSP-2e-Thi; lane 7, Sj-23-GST-His as a control protein.
doi:10.1371/journal.pntd.0001166.g004
Inconsistent Vaccine Efficacy of S.japonicum TSP-2
www.plosntds.org 6 May 2011 | Volume 5 | Issue 5 | e1166
worm burdens or egg counts (data not shown). Overall, the trials
showed that Sj-TSP-2e did not induce any consistent protection in
mice against a S. japonicum challenge infection.
Discussion
We report that vaccinating mice with the large extracellular loop
(LEL) of Sj-TSP-2e (expressed in E. coli) from S. japonicum did not
induce consistent protective efficacy. Yuan et al. [9] cloned and
expressed Sj-TSP-2d and showed that the molecule induced
significant levels of protection, although Sj-TSP-2c [8] and, as
shown here also, Sj-TSP-2e did not induce any significant
protection, suggesting that different subclasses of Sj-TSP-2 may
stimulate different levels of protective efficacy. The serum IgG titres
in the mice we vaccinated with Sj-TSP-2e were elevated after the
second vaccination (Fig. 7) and ranged from 1:320,000 to 1:640,000
(data not shown) before challenge, which were lower than those in
mice vaccinated with Sm-TSP-2 in the study by Tran et al. [5]. We
used the same quantity of Sm-TSP-2 and the same vaccination
procedure and schedule, and the serum titre in the group reached
1:320,000 against Sm-TSP-2 (data not shown). We also expressed
Sj-TSP-2e in yeast (Fig. 4, lane 5) and the resulting 6His tagged
protein a stimulated a very IgG high titre (.1:3,000,000; data not
shown) of murine antibodies. However, the mice were not protected
against a challenge infection with S. japonicum (data not shown),
indicating the serum titres (ranging between 1:320,000 to
1:3,000,000) showed no correlation with protective efficacy.
We showed that Sj-TSP-2e specifically stimulated mice to
produce IgG1 and IgG2 antibodies, which was similar to that
reported with Sm-TSP-2 in vaccinated mice [5]. The levels of the
Figure 5. Recognition of recombinant Sj-TSP-2e by human sera. I: ELISA IgG screen of 72 sera collected from positive schistosomiasis
japonica patients and 24 normal human sera (negative controls) probed by protein preparation from S. japonicum adult worms (SWAP), recombinant
tag protein thioredoxin (Thio) and Sj-TSP-2e. II. Panel a: SDS-PAGE of soluble and insoluble protein extracted from adult S. japonicum and
recombinant Sj-TSP-2e. Panels b and c: Western blot analysis with pooled sera randomly selected from confirmed schistosomiasis japonica patients
(n = 15) and pooled sera from negative control subjects (n = 15) from northern China. Lane M, protein markers; lanes 1 and lane 2, soluble and
insoluble proteins from adult S. japonicum; lane 3, Sj-TSP-2e (arrowed); lane 4, thioredoxin tag (Thi) (arrowed); lane 5, Sj-TSP-2e expressed in Pichia
yeast (arrowed).
doi:10.1371/journal.pntd.0001166.g005
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two subclasses of IgG are recognised as markers of Th1 (IgG1) and
Th2 (IgG2) responses [19,20], which normally inhibit each other.
It would be valuable to determine whether Sj-TSP-2e can actually
stimulate the two types of T cell. Generally, a Th1 response is
positively associated with protective immunity, whereas a Th2
response likely benefits parasite survival in the mammalian host
[21,22]. Based on previously published data and those presented
here, we believe it is premature to speculate whether Sj-TSP-2 is
suitable for vaccine development against schistosomiasis japonica.
Given the protein is located in the schistosome tegument and
appears to be highly polymorphic, it likely plays a role in
avoidance of the host immune response. It is not known whether
the protein is important for parasite growth and what its
relationship is with other tetraspanins in schistosomes. A recent
study using RNA interference to silence expression of Sm-TSP-2
mRNAs in S. mansoni adults and schistosomula resulted in
Figure 6. Immunolocalization of S. japonicum Sj-TSP-2e in adult female worms. Parasite sections were reacted with specific antibodies
produced in mice against recombinant Sj-TSP-2e. The antibodies that specifically bound to the sections were probed with an anti-mouse IgG labelled
with Cy3 conjugate (a, c). Red fluorescence in panel c indicates Sj-TSP-2e is located in the parasite tegument (teg); anti-thioredoxin (fusion protein
tagged with 6His) antibodies in panel a did not react. DAPI to label nuclei (nuc in blue) (b, d) was used as a quality control marker for the sections.
Tegument, teg.
doi:10.1371/journal.pntd.0001166.g006
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impaired turnover of the tegument apical membrane complex,
suggesting Sm-TSP-2 plays an important structural role impacting
on the development, maturation or stability of the schistosome
tegument [6].
As most sequences of the Sj-TSP-2 subclasses are identical, it
was difficult to design specific primers to distinguish each of the
subclasses by real time PCR. Instead, we designed a pair of
universal primers which amplify all the subclasses of Sj-TSP-2 to
show the overall expression of the genes. The expression levels of
the gene(s) were normalized against cercariae which showed that
the gene expression in males was 5 times higher than in females
(Fig. 3). However, EST sequencing of individual males and
females showed that each of the subclasses was different in terms of
their frequency (Table 2), indicating these subclasses of Sj-TSP-2
are differentially expressed in male and female S. japonicum. The
results showed that Sj-TSP-2e was predominantly expressed in
females, suggesting the gene is likely associated with female
development. This can also help to explain the minimal amount of
stain evident in sections of males, compared with female worms, in
the immunohistological analysis undertaken with specific anti-Sj-
TSP2e antibodies.
The polymorphism of Sj-TSP-2 is a major concern for
developing this molecule as an anti-S. japonicum vaccine. We
aligned 211 clones from S. japonicum and showed that there are at
least 7 different clusters of Sj-TSP-2 cDNA sequences. It is not
clear whether the variation is caused by transcription from
different genes or alleles. BLAST analysis of S. japonicum genomic
sequences with a full-length Sj-TSP-2 cDNA including the 39UTR
(EF634060) found only one copy of the gene with 5 exons in the
genome (data not shown), suggesting that the variation is likely due
to the presence of different alleles. If so, it will be informative to
determine how many alleles of Sj-TSP-2 exist. Combining our
findings with those of Cai et al [8], there are a total of 9 different
clusters/subclasses, suggesting at least 9 alleles based on the
variable region of Sj-TSP-2. In addition, we identified one single
worm that had three different cDNA clusters (data not shown),
which is similar to previous findings [8] which showed that two Sj-
TSP-2 genomic fragments could be amplified from a single worm,
indicating S. japonicum has 2 copies of the Sj-TSP-2 gene at different
loci in its genome, with one copy having two alleles and another
having the same allele.
Considering all the sequences have the same number of
nucleotides in the ORF encoding homologous protein sequences,
these variable sequences have likely arisen from different alleles of
Sj-TSP-2. To determine whether they belong to different genes, we
searched their identical sequences in the Genbank databases and
aligned their 39 UTRs. We found a variable region with different
numbers of nucleotides in the 39 UTR, with the variation
paralleling that in the large loop (Fig.S1); the gaps in some
sequences indicate the possibility of the presence of different genes
(Fig. S1). Two sequences - FN319825 and FN319885 - share the
same ORF encoding Sj-TSP-2f, but have different 39 UTR
nucleotides, indicating the same protein is transcribed from
different genes in the S. japonicum genome.
In contrast to Sj-TSP-2, there is evidence that Sm-TSP-2
exhibits very limited variation in its cDNA sequence suggesting
that the gene in S. mansoni is conserved (Cupit PM et al. (2010) An
investigation of polymorphism in the tetraspanin-2 gene of
Schistosoma mansoni field isolates. Am J Trop Med Hyg Abstract
Book, 59th Annual Meeting p123; Charles Cunningham, personal
communication). This may reflect the fact that S. mansoni infects
only humans and a limited number of other definitive host species,
Figure 7. Antibody isotype levels in mice challenged with 35 S. japonicum cercariae. Mouse serum anti-Sj-TSP-2e (fused with thioredoxin,
Thi) antibodies were determined by ELISA after primary vaccination with S. japonicum-TSP-2e (Sj-TSP-2e) or S. mansoni-TSP-2 (Sm-TSP-2). Thioredoxin
was used as control protein in the vaccine trials. The thin arrows indicate vaccination time points and the bold arrows indicate the time point of
cercarial challenge.
doi:10.1371/journal.pntd.0001166.g007
Table 2. Vaccination results of mice vaccinated with SjTSP-2e against challenge infection with Schistosoma japonicum cercariae.
Trial Worm burden Eggs in whole liver Eggs in one gram of faeces
Protein
Range
(worm
pairs) Mean ± SD Med
Redu
(%) P value Mean ± SD Med
Redu
(%) P value Mean ± SD Med
Redu
(%)
P
value
Trial 1 (HDC)
Thi 18–29(7.8) 23.263.1 22 - - 53488616407 59508 - - ND - -
Sj-TSP2 3–14(3.9) 15.463.2 14 36.4 0.0004 37868616286 43764 26.5 0.019 ND - -
Sm-TSP2 4–18(4.9) 19.164.4 19.5 11.4 0.032 40041632551 28743 51.7 0.075 ND - -
Trial II (HDC)
Thi 10–32(10.1) 20.066.3 21 - - 97407636537 112216 - - 479162969 5714 - -
Sj-TSP2 2–23(6.8) 14.366.0 16.5 21.4 0.065 95833631066 99339 11.5 0.842 450962870 4067 28.8 0.806
Sm-TSP2 2–24(6.8) 15.767.6 16.5 21.4 0.306 90671649179 107768 4.0 0.968 453765752 3341 41.5 0.326
Trial III (LDC)
Thi 2–11(2.7) 8.3362.8 9 - - 21176616629 23966 - - 6376643 560 - -
Sj-TSP2 6–12(1.6) 8.3062.1 7.5 16.7 0.679 20513623301 10921 54.4 0.326 4506561 179.3 68.9 0.251
Sm-TSP2 3–10(1.5) 7.3062.6 7.0 22.2 0.266 11726613051 6962 70.9 0.067 3786356 340 41.0 0.235
Note: Thi, thioredoxin, as tag protein expressed in E. coli was used as a control protein. Sj-TSP2, Sj-TSP-2e; Sm-TSP2, Sm-TSP-2. Med, median; Redu, reduction = (1-
number of median worms or eggs in experimental group/number of median worms or eggs in control group)6100%; ND, no data. HDC, high dose challenge with 35
cercariae; LDC, low dose challenge with 12 cercariae.
doi:10.1371/journal.pntd.0001166.t002
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whereas S. japonicum utilizes a wide range of final hosts including
humans and other mammals including cats, dogs, goats, horses,
pigs, rats and water buffaloes. In China, S. japonicum can mature in
over 40 species of domestic and wild mammalian hosts [23]. It is
likely that the selection pressure provided by the various
mammalian host species that S. japonicum infects promotes the
development of mutated gene sequences as is evident in Sj-TSP-2,
a feature that may be associated with its adaptation to the various
host assemblages, a trait characteristic of a number of other
parasitic helminths [24,25,26].
Signal prediction analysis showed the first 33 residues of the Sj-
TSP-2 sequence represent a signal peptide which is encoded by the
first exon of the genomic sequence. This region is highly conserved
in both the Sj-TSP-2 and Sm-TSP-2 sequences (data not shown).
The variable region is located in the middle of the TSP sequences
and is encoded by three exons. The phylogenetic analysis of the
large extracellular loop region we undertook showed that the 12
unique sequences occurring in S. japonicum fell into two poorly
supported clusters, within which some subclustering occurred.
Two clusters had clade credibility values over 95%: (Sj-TSP-2c, Sj-
TSP-2h, Sj-TSP-2i) and (Sj-TSP-2g, Sj-TSP-2f, CAX70617_Sj),
Fig. 2.
It is noteworthy that a number of different tetraspanins (at least
23 different genes deposited in the GenBank databases), including
Sj23 and Sj25, have been described in S. japonicum [4,5,8,9,27,28];
a recent report showed that Sj23 was able to induce very
encouraging levels of protection in Chinese water buffaloes
experimentally challenged with S. japonicum [27]. It is important
to determine how many types of Sj-TSP-2 gene are present in S.
japonicum and the distribution of these different subclasses/alleles in
S. japonicum populations from different endemic areas. This is
fundamental for further consideration of Sj-TSP-2 as a vaccine
target, and such analysis will increase knowledge of the possible
role of this polymorphic protein in modulating immunity and the
mechanisms whereby schistosomes are able to evade the host
immune response.
Supporting Information
Figure S1 Parallel alignment of variable and 39 UTR sequences
of 7 clusters of Sj-TSP-2. The comparison shows some gaps in
some sequences indicating the possibility of the presence of
different genes. GenBank accession numbers for the sequences are
listed on the left hand of panel A.
(TIF)
Figure S2 Transmembrane domains of Sj-TSP-2e generated by
MacVector 8.0.
(TIF)
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